Successful treatment of pediatric patients with high-grade gliomas featuring leptomeningeal metastases by targeting BRAF V600E mutations with dabrafenib plus trametinib: two illustrative cases
This report shows that dabrafenib and trametinib are effective not only for recurrent lesions but also for LMM in pediatric patients.
Source: International Cancer Conference Journal - Category: Cancer & Oncology Source Type: research
More News: Brain | Brain Cancers | Brain Tumor | Cancer | Cancer & Oncology | Conferences | Craniotomy | Glioma | Neoplastic Meningitis | Neurology | Pediatrics